Estrella Immunopharma, Inc. (ESLA) vs Neuphoria Therapeutics Inc. (NEUP)

Estrella Immunopharma, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Estrella Immunopharma, Inc. and Neuphoria Therapeutics Inc. are of similar size ($20.5M and $19.8M). Across the 8 metrics below, Estrella Immunopharma, Inc. leads on 6 and Neuphoria Therapeutics Inc. on 2.

Valuation

Metric ESLA NEUP Biotechnology median
P/E n/m n/m 7.88
P/S n/m 1.02 11.47
P/B n/m 0.65 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.17 0.74
EV/Sales n/m (0.19) 10.73
Earnings yield (50.81%) (138.08%) (28.84%)
Free cash flow yield (45.47%) (76.04%) (23.03%)

Profitability

Metric ESLA NEUP Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 148.05% (61.70%) (57.72%)
Return on assets (416.74%) (46.95%) (49.22%)
Return on invested capital 0.00% (232.67%) 0.00%

Growth

Metric ESLA NEUP Biotechnology median
Revenue growth (TTM) — 3,535.05% 5.64%
EPS growth (last fiscal year) (188.78%) (1,230.43%) —
Revenue growth, 5-year CAGR — 19.07% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ESLA NEUP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.20 27.85 4.73
Net debt to EBITDA 0.11 1.26 0.96

Dividend

Metric ESLA NEUP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ESLA NEUP Biotechnology median
Market cap 20.49m 19.75m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack